12/04/2012 - Press release
Researchers at the Hospital de Mar Research Institute (IMIM) have discovered that the protein LOXL2 has a function within the cell nucleus thus far unknown. They have also described a new chemical reaction of this protein on histone H3 that would be involved in gene silencing, one of which would be involved in the progression of breast, larynx, lung and skin tumours.
Més informació "New advances in the understanding of cancer progression"
14/03/2012 - Press release
A study lead by the IMIM (Hospital del Mar Research Institute) and the Barcelona Public Health Agency (ASPB) has shown that the level of Persistent Organic Pollutants (POPs) in blood has dropped significantly in the inhabitants of Barcelona between the years 2002 and 2006. It is the first time that the temporary evolution of the concentration of persistent organic pollutants in humans is studied with a representative sample and using the same method.
20/12/2012 - Press release
A study by the Healthcare Services Research Group at the IMIM has studied the per-patient costs associated with the pandemic influenza virus type H1N1, also called influenza A, from 2009. The study, has centred on the use of healthcare resources and sick leave due to employees’ temporary disability. This influenza affected more than 74 countries and caused some alarm due to its being declared pandemic and because several forecasts placed its financial burden at very high levels.
Més informació "Non-hospital resources, the highest health cost of influenza A"
16/02/2012 - Press release
The study proved that all of parents’ mental disorders are associated with a higher tendency of suicidal ideation among their children, but only generalised anxiety and depression are associated with the actual elaboration of suicide plans and the persistence over time of suicidal ideation, while parents’ antisocial personality and anxiety disorders are associated with children attempting suicide and its persistence over time.
23/01/2012 - Press release
Doctors and researchers of Hospital del Mar and IMIM point to an acquired mutation during treatment as the causative mechanism of therapeutic failure. This discovery leads to new perspectives to improve the efficiency of treatments, the survival of patients and to advance in customized treatments against cancer
Més informació "Identified a cause of resistance to colon cancer treatment"
25/12/2011 - Press release
For the first time, it has been discovered that neutrophils exist in the spleen without there being an infection. This important finding made by the research group on the Biology of B Cells of IMIM (Hospital del Mar Research Institute) in collaboration with researchers from Mount Sinai in New York, has also made it possible to determine that these neutrophils have an immunoregulating role.
Més informació "Discovered the existence of neutrophils in the spleen"
04/12/2011 - Press release
Nature Medicine publishes a pioneering study about a protein that regulates the expression of hundreds of genes that have a crucial role in the progression of pancreatic cancer, gliomas and possibly many other kinds of tumor. The study is directed by Pilar Navarro at the IMIM (Institut de Recerca Hospital del Mar, Barcelona) and Raúl Méndez, ICREA Research Professor at the Institute for Research in Biomedicine (IRB Barcelona).
Més informació "Discovery of a new reprogramming mechanism for tumor cells"
11/11/2011 - Press release
A study lead by a team of researchers from the Hospital del Mar and its research institute, IMIM, concludes that post-menopausal women with osteoarthritis have a 20% greater risk of experiencing bone fractures due to osteoporosis and are at greater risk of falling –nearly 30% more than post-menopausal women without osteoarthritis
26/10/2011 - Press release
New guidelines which provide an easy to use checklist for the accurate and ethical reporting of studies involving genetic or molecular risk factors for disease have been proposed by a group of international researchers among them Miquel Porta, head of the group of Clinical and molecular epidemiology of cancer at IMIM (Hospital del Mar Research Institute), and are published in this week’s PLoS Medicine
13/10/2011 - Press release
The Spanish Society of Cardiology (Sociedad Española de Cardiología or SEC) warns that the percentage of the Spanish population with a good control of cardiovascular risk factors is no higher than, at best, 65%, and at worst, 34%.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact